Trontinemab

Approval Year

Substance Class	Protein Created by `admin` on `Sat Dec 16 14:53:35 GMT 2023` Edited by `admin` on `Sat Dec 16 14:53:35 GMT 2023`
Protein Type	BISPECIFIC ANTIBODY
Protein Sub Type	IGG1
Sequence Origin	HUMAN (AGAINST AMYLOID-BETA), HUMANIZED RABBIT (AGAINST TRANSFERIN RECEPTOR)
Sequence Type	COMPLETE
Record UNII	N0GBZ1GWC2
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

Trontinemab

Official Name

English

RG6102

Code

English

immunoglobulin [G1-VH-Ckappa_Vkappa-CH1]_[G1_kappa] with domain crossover, anti-[Homo sapiens APP (amyloid beta, A4 precursor protein) Abeta, conformational epitope 1-40/42)] and anti- [Homo sapiens TFRC (transferrin receptor, p90, CD71)], humanized mono

Common Name

English

RO-7126209

Code

English

Immunoglobulin G1 [156-glutamic acid,222-glutamic acid,363-cysteine,375-tryptophan,de-456-lysine], anti-(human β-amyloid 1-40/42) (human clone mAb31 γ1-chain) fusion protein with peptide linker (GGS(GGGGS)3) fusion protein with immunoglobulin anti-(hum

Common Name

English

RO7126209

Code

English

RG-6102

Code

English

RECOMBINANT (2+1) BISPECIFIC HUMANIZED MONOCLONAL ANTI-A-BETA PEPTIDE AND BINDS TO TRANSFERRIN RECEPTOR (TFR).

Common Name

English

trontinemab [INN]

Common Name

English

TRONTINEMAB [USAN]

Common Name

English

Code System Code Type Description

CAS

2568868-35-7